Medical Research News

Focus on the latest clinical studies, reports, findings, programs and standards covering a wide spectrum of medical and health issues. This section highlights research into human populations and includes information about research facilities, funding, resources and public policy.

ALPCO Releases Versatile and Economical Chemiluminescent Plate Reader

ALPCO Releases Versatile and Economical Chemiluminescent Plate Reader

ALPCO has launched its new STELLUX® Chemiluminescent Plate Reader, an economical and versatile system for any size lab. - September 20, 2016 - ALPCO

Rainforest Educator, John Easterling, Kicks Off 6th Annual Association of Natural Health Conference in Douglasville, Ga on October 13 (Full Conference October 13-15)

Rainforest Educator, John Easterling, Kicks Off 6th Annual Association of Natural Health Conference in Douglasville, Ga on October 13 (Full Conference October 13-15)

Achieving Balance and Restoring Health. The Association of Natural Health will be presenting dynamic natural health leaders October 13 - 15 at the Douglasville Conference Center, 6700 Church Street, Douglasville, GA October 13 - 15, 2016. Keynote presentations include: Rainforest Botanicals for Radiant Health, Healing the Gut, Mastering Metabolic Chaos, Methylation's Role in Neurological Health, Neurotransmitters: The Foundation of Our Biochemistry, Art is a Path to Wellness. - August 26, 2016 - Association of Natural Health

Cofactor of BRCA1: A Promising Genetic Marker for Common Malignant Liver Cancer Therapy, According to PiscoMed's Oncology Journal AMOR

Researchers found strong indication of COBRA1’s involvement in the growth and metastasis of hepatocellular carcinoma. - August 26, 2016 - PiscoMed Publishing Pte Ltd

Clinical Trial Supplies

Clinical Trial Supplies

Clinical Trial Supplies 2nd Annual Symposium will be held in Brussels on the 20th and 21st of October 2016. CTS is a meeting dedicated in exploring the medical supplies required for Clinical Trials and Operations. Presented by prestigious pharmaceutical and biotechnology companies globally engaged... - August 25, 2016 - Business Dialogue

PlantVax Contracted for Key Enzyme Production in Chemical Warfare Disclosure Sprays

PlantVax Contracted for Key Enzyme Production in Chemical Warfare Disclosure Sprays

PlantVax, Inc. has been contracted by a tier one US defense contractor as the primary supplier of Recombinant Human Acetylcholinesterase (AChE) in support of a Program of Record chemical warfare disclosure spray. The disclosure spray is a first-of-its-kind plant derived enzyme-based sensor that... - August 23, 2016 - Huckworthy LLC

ALPCO’s New and Improved Adiponectin ELISAs Allow Researchers to Confidently Study Type 2 Diabetes

ALPCO’s New and Improved Adiponectin ELISAs Allow Researchers to Confidently Study Type 2 Diabetes

ALPCO has released new and improved versions of their Total Adiponectin and HMW & Total Adiponectin ELISAs which allow researchers to confidently measure adiponectin for the study of high molecular weight (HMW) to total ratios. - August 17, 2016 - ALPCO

Robert W. McIntosh, Ph.D. Honored as a Professional of the Year by Strathmore's Who's Who Worldwide Publication

Robert W. McIntosh, Ph.D. Honored as a Professional of the Year by Strathmore's Who's Who Worldwide Publication

Robert W. McIntosh, Ph.D. of Pearl City, Hawaii has been honored as a Professional of the Year for 2016 by Strathmore’s Who’s Who Worldwide for his outstanding contributions and achievements in the fields of research and development in basic neurosciences and governmental consulting in... - August 16, 2016 - Strathmore Worldwide

HealthAxis Group, USF Partners on Parkinson’s Research Project

Researchers will be able to study whether a group of commonly used drugs affect the onset of Parkinson’s disease, thanks to a new grant partnership between the University of South Florida and HealthAxis Group. - August 16, 2016 - HealthAxis Group

Medical Technology and Practice Patterns Institute Announces That It Has Been Awarded an R01 Research Grant by the Agency for Healthcare Research and Quality

Medical Technology and Practice Patterns Institute Announces That It Has Been Awarded an R01 Research Grant by the Agency for Healthcare Research and Quality

The Medical Technology and Practice Patterns Institute, Inc. (MTPPI) announces that it has been awarded an R01 research grant by the Agency for Healthcare Research and Quality (AHRQ). The grant will be used to investigate the impact of the End-Stage Renal Disease Prospective Payment System (ESRD PPS) reform that was enacted by Congress in 2011. - August 11, 2016 - Medical Technology and Practice Patterns Institute

Chinese Pharma Market Prospects Remain Robust as New Drivers Emerge

Chinese Pharma Market Prospects Remain Robust as New Drivers Emerge

Despite slowing Chinese pharma market growth to 7.6% in 2015, it remains a high growth spot with numerous emerging opportunity areas, according to the China Pharmaceutical Guide 2016 (11th Edition). Hot off the press, the China Pharmaceutical Guide 2016, an indispensable reference for MNC executives with China responsibilities for over a decade, aims to help proactive HQ and local executives feel the pulse of Chinese healthcare and stay in the driver seat of their business in the country. - August 09, 2016 - WiCON International Group LLC

Baebies to Exhibit and Display FINDER Prototype at 2016 AACC Annual Scientific Meeting

Baebies, Inc., a company focused on advancing newborn screening and pediatric testing, today announced that the company will exhibit and display a prototype of FINDERTM at the 68th AACC Annual Scientific Meeting and Clinical Lab Expo. FINDER, currently under development, is a small, innovative and... - July 28, 2016 - Baebies, Inc.

Bioscience Americas Outlines Growth Strategy

Opportunities abound for the world's leading developer of autologous stem cell treatment centers. - July 19, 2016 - Bioscience Americas

Reilly H. Stewart Honored with the Lifetime Achievement Award by Strathmore's Who's Who Worldwide Publication

Reilly H. Stewart Honored with the Lifetime Achievement Award by Strathmore's Who's Who Worldwide Publication

Reilly H. Stewart of Indio, California has been honored with the Lifetime Achievement Award by Strathmore’s Who’s Who Worldwide for his outstanding contributions and achievements in the field of healthcare. This award is presented to those individuals who have made a difference in the... - July 19, 2016 - Strathmore Worldwide

Academy Medical Partnership with Acelity Strengthens Regenerative Medicine Offering to Federally Funded Medical Facilities

Academy Medical Partnership with Acelity Strengthens Regenerative Medicine Offering to Federally Funded Medical Facilities

Service-Disabled Veteran-Owned Small Business, Academy Medical, has forged a partnership with Acelity, a globally diversified wound care and regenerative medicine company, to distribute the company’s full line of regenerative medicine products including ALLODERM™ Regenerative Tissue Matrix and STRATTICE™ Reconstructive Tissue Matrix within the Department of Veterans Affairs (VA) and Indian Health Services (IHS) centers. - July 12, 2016 - Academy Medical

Patricia A. Cleary Honored as a VIP for Two Consecutive Years by Strathmore's Who's Who Worldwide Publication

Patricia A. Cleary Honored as a VIP for Two Consecutive Years by Strathmore's Who's Who Worldwide Publication

Patricia A. Cleary of Arlington, Virginia has been honored as a VIP for two consecutive years, 2015 and 2016, by Strathmore’s Who’s Who Worldwide Edition for her outstanding achievements and success in the field of education. About Patricia A. Cleary Ms. Cleary has 50 years experience... - July 09, 2016 - Strathmore Worldwide

Prosidyan Announces an Exclusive Joint Collaboration and License Agreement with MO-SCI Corporation for an Exciting New Technology

Prosidyan Announces an Exclusive Joint Collaboration and License Agreement with MO-SCI Corporation for an Exciting New Technology

New Jersey based company Prosidyan, Inc. (www.prosidyan.com), developer of proprietary fiber-based bioactive glass orthobiologics products, announced today that it has entered into an exclusive joint collaboration and license agreement with MO-SCI Corporation of Rolla, Missouri for an exciting new... - June 30, 2016 - Prosidyan, Inc.

TrialX Launches Trialspace at DIA 2016 – An Easy to Use Clinical Trials Website Builder with Built-in Recruitment Tracking Tools to Launch Your Study Website in Minutes

TrialX announces the launch of Trialspace, a clinical trial website builder (http://trialx.com/trialspace) for sponsors, CROs, patient recruitment agencies and investigators. Trialspace comes with a sophisticated patient referral and recruitment tracking engine that is easy to use and provides a... - June 24, 2016 - Applied Informatics

Leading Scientists on Neuroplasticity Present at Brain IDEAS Symposium, Aug. 5th

Leading Scientists on Neuroplasticity Present at Brain IDEAS Symposium, Aug. 5th

Invisible Disabilities Association is hosting their 2nd Annual Brain IDEAS Symposium on Aug. 5th in Denver, CO focusing on Brain Disorders, Brain Health, and Brain Therapy. 9 expert presenters will each deliver dynamic, science and story-filled talks on topics including Neuroplasticity, ADHD, ADD, Autism, Learning Disabilities, Dyslexia, Alzheimer’s, Nutrition, Microbiome, Mental Training, Therapeutic Humor, Stroke, PTSD, EMDR and TBI followed by 3 Expert Led Panels for questions and answers. - June 17, 2016 - Invisible Disabilities Association

Virun® Receives U.S. Patent 9,351,517 for Its Vitamin E, Esolv®, All-the-While Rebranding Itself as a Notable Formulation and Development Giant

Virun® Receives U.S. Patent 9,351,517 for Its Vitamin E, Esolv®, All-the-While Rebranding Itself as a Notable Formulation and Development Giant

Soon after international patent approval, Virun receives U.S. patent 9,351,571 for its principle technology, Esolv®. As research continues to show oils, fats and non-polar compounds have strong and growing efficacious health claims, the need to incorporate these compounds into foods, beverages and supplements will become even more sought-after. VIRUN’s extensive Portfolio, including Esolv®, is accelerating innovation. What Virun has created is notably notable in a noticeable way. - June 16, 2016 - VIRUN

US Researchers Call for Re-Evaluation of Microbial Testing of Cannabis Following New, Sequencing-Based Study

A new US study suggests that some of the medicinal benefits of dispensary grade Cannabis could be compromised because the flowers host potentially harmful yeasts and toxic molds, which cannot be detected by industry standard culturing techniques. The report, ‘Cannabis microbiome sequencing... - June 16, 2016 - Faculty of 1000

NanoHybrids to Sponsor Gold Nanoparticles for Selected Research Proposals

For a limited time, NanoHybrids is accepting applications for a chance to win a supply of their top Gold Nanoparticles to enhance imaging project results. - June 10, 2016 - NanoHybrids

ALPCO Releases New Broad Range Periostin ELISA

ALPCO Releases New Broad Range Periostin ELISA

ALPCO now has a new broad range Periostin ELISA capable of measuring elevated levels of periostin consistent with current research. - June 07, 2016 - ALPCO

TriFoil Installs Russia’s First 3D Optical Imager in Novosibirsk

TriFoil Installs Russia’s First 3D Optical Imager in Novosibirsk

In February 2016, TriFoil Imaging in collaboration with GenMedica Baltic Ltd and assistance of BioVitrum Ltd installed Russia’s first 3D Optical imaging system, the InSyTe FLECT/CT. The system was installed under the operation of Prof. Evgeny Zavyalov, head of SPF Vivarium Department of... - May 17, 2016 - TriFoil Imaging

Doctors Use Bitcoin Tech to Improve Transparency in Clinical Trial Research

Two clinicians have devised a new system to prevent clinical trial documents being secretly altered to make new medications look more effective than they are. The new method aims to solve this problem using blockchains, the technology that underpins the virtual currency Bitcoin. - May 13, 2016 - Faculty of 1000

Dare to Rise - Reshaping Humanity by Reshaping Yourself

Dare to Rise - Reshaping Humanity by Reshaping Yourself

A brand new book by Maria Teresa De Donato Ph.D and Denis Gorce-Bourge. Dare to Rise is written for the many people who feel a calling for more “awareness in living,” who are looking to grow more consciously and find clear understanding of the mechanics of responsibility in action. - May 03, 2016 - GB Life Coaching Ltd

ALPCO’s Bioactive Leptin ELISA Allows Researchers to Differentiate Between Leptin Resistance and Non-functional Leptin

ALPCO’s Bioactive Leptin ELISA Allows Researchers to Differentiate Between Leptin Resistance and Non-functional Leptin

ALPCO recently announced the release of its Bioactive Leptin ELISA, offering diabetes and obesity researchers a new tool to differentiate between leptin resistance and non-functional leptin. The assay allows for the measurement of leptin in human serum through the process of binding leptin to... - April 26, 2016 - ALPCO

Bioquark Inc. and Revita Life Sciences Receive IRB Approval for First-In-Human Brain Death Study

Bioquark Inc. and Revita Life Sciences Receive IRB Approval for First-In-Human Brain Death Study - The Reanima Project - Is Death Reversible? - April 25, 2016 - Bioquark Inc.

Fahad Al Tamimi to Host a Special Dinner in Support of Research Into Radiation Therapy

Fahad Al Tamimi to Host a Special Dinner in Support of Research Into Radiation Therapy

Fahad Al Tamimi will welcome high profile guests in London next week to support further research into the area of radiation therapy. - April 22, 2016 - Fahad Al Tamimi Philanthropy

Morgan's Fund Issues Statement on Selection for NORD's Natural History Studies Project

A statement was issued today by Stephanie M. Vaughan, Co-founder and President of The Morgan Leary Vaughan Fund (Morgan’s Fund), regarding the announcement of the National Organization for Rare Disorders’ (NORD) selection of Natural History Studies Project participants. - April 22, 2016 - The Morgan Leary Vaughan Fund, Inc.

Omni International Launches Bead Mill Specific DNA and RNA Purification Kits

Omni International, Inc. today announced the release of a series of nucleic acid purification kits specifically designed for use with bead mill homogenizers like the Omni Bead Ruptor bead mill homogenizer line. These kits contain custom reagents that enhance nucleic acid recovery and ensure high... - April 22, 2016 - Omni International

Virun® at Ingredient Marketplace, Patent Grant in S. Korea, New Product Launches, Debut of Lightbulb Virun T-Shirts, and Webinar Controversy

Virun® at Ingredient Marketplace, Patent Grant in S. Korea, New Product Launches, Debut of Lightbulb Virun T-Shirts, and Webinar Controversy

VIRUN® plans on taking Orlando by storm at Ingredient Marketplace, where Virun’s Esolv® technology will take center stage, and Virun’s unique Omega smoothies and beverages will be available for sampling. South Korea granted Virun yet another patent protecting its unique technology. Virun launches new products and a new t-shirt. Virun’s latest webinar, “Inside Virun,” sparks controversy, and provides new business opportunities. - April 12, 2016 - VIRUN

Rejenavite, LLC Publishes Study Demonstrating Fucus Vesiculosus Seaweed Effectively Treats Inflammatory Bowel Disease in Animals

Rejenavite, LLC has published a new study from University of Tasmania Faculty of Health demonstrating fucoidan sourced from Fucus vesiculosus taken orally significantly reduces IBS symptoms. - April 07, 2016 - Rejenavite, LLC

ALPCO's New Chemiluminescent IL-6 ELISA Delivers Flexibility and Cost Savings

ALPCO's New Chemiluminescent IL-6 ELISA Delivers Flexibility and Cost Savings

ALPCO announced the launch of its new STELLUX® Chemi Human IL-6 ELISA - the first cytokine assay in the STELLUX® Chemiluminescence product line. - April 06, 2016 - ALPCO

Blazers VS Nugs Portland Trailblazers Take on the Denver Nuggets for the Blazers Last Home Game of the Season

Blazers VS Nugs Portland Trailblazers Take on the Denver Nuggets for the Blazers Last Home Game of the Season

The Seattle SuperChronic Cafe Presents "Blazers VS Nugs" private suite (sky-box) at the Moda Center with retired Trailblazer Cliff Robinson, aka Uncle Spliffy Wednesday April 13th. This event at the Blazers VS Nuggets NBA game is an opportunity to normalize cannabis in a professional setting, while promoting an ‪Active Cannabis Lifestyle. More on FB @SuperChronic_Cafe - April 05, 2016 - SuperChronic Cafe

Europe is Leading in the Global Radioimmunoassay Market in 2015 – a New Report by Data Bridge Market Research

Europe Radioimmunoassay Market Trends and Forecast to 2022 – By Product Type (Kit, Analyzer), By End User (Hospitals, Lab, Others), By Application (Diagnostic, Research) By Geography - March 27, 2016 - Data Bridge Market Research

Reilly H. Stewart Honored on the Reuter's Billboard in Times Square, New York City by Strathmore's Who's Who Worldwide Publication

Reilly H. Stewart Honored on the Reuter's Billboard in Times Square, New York City by Strathmore's Who's Who Worldwide Publication

Reilly H. Stewart of Indio, California was honored on the Reuter’s Billboard in Times Square in New York City by Strathmore’s Who’s Who Worldwide for his outstanding contributions and achievements in the field of healthcare. He has also been recognized as a Professional of the... - March 25, 2016 - Strathmore Worldwide

AABC Researchers Discover Major Cause Of Obesity

AABC Research Fellows Identify “The Missing Link.” A New and Important Metric, in Understanding Why Some People Are Thin and Others Thick Despite Similar Caloric Intake. - March 24, 2016 - American Association of Bariatric Counselors

Hematogenix Laboratory Services, LLC Announces the Availability of FDA Approved PD-L1 Companion Diagnostic Tests

Hematogenix Laboratory Services Announces the Availability of PD-L1 Companion Diagnostic Tests for KEYTRUDA®, Merck's Anti-PD-1 Therapy for Metastatic Non-Small Cell Lung Cancer Whose Tumors Express PD-L1 with Disease Progression on or after Platinum-Containing Chemotherapy as well as a PD-L1 Complementary Diagnostic Test to Support Bristol-Myers Squibb's OPDIVO® Anti-PD-1 Therapy for Non-Squamous Non-Small Cell Lung Cancer. - March 24, 2016 - Hematogenix

Dr. Lazenby Helps Attorneys Win Larger Verdicts Using Documentation Based on the 3 Phases of Healing to Support Patients Soft Tissue Spinal Injury Claim

Dr. Lazenby Recently Supported His Patients Soft Tissue Spinal Injury Claim Using Computerized Radiographic Mensuration Analysis, the Science of the 3 Phases of Healing and a Medical Team Approach. - March 24, 2016 - Dr. Kerry Lazenby

TrialX Launches America Walks, the First Mobile-Based Walking Study on iOS and Android Using Apple’s ResearchKit Technology

TrialX announced the launch of “America Walks,” a mobile based research study (http://trialx.com/americawalksstudy) to determine the walking behavior of Americans. The study is the first mobile app based study to be available on both iOS and Android devices. The America Walks App has been built using Apple’s ResearchKit Library and the team at TrialX has also ported the same for Android devices so that the app is available to a much larger population base. - March 24, 2016 - Applied Informatics

ACRP and CRO Analytics to Present Site Voice™ Findings at Executive Summit on Site Strategies

CRO Analytics and the Association of Clinical Research Professionals (ACRP) will present data and findings generated through the collaborative development of Site Voice™, a cloud-based platform designed to gather information from clinical research sites, during the ACRP Executive Summit on... - March 23, 2016 - CRO Analytics

A Tale of Two New Hepatitis C Drugs

A Tale of Two New Hepatitis C Drugs

Despite discount, Merck’s just approved Zepatier unlikely to win share with most US payers, except in Medicaid, according to RxScorecard™. New combo from Gilead could ensure company’s dominant position among US payers. - March 11, 2016 - Real Endpoints

Hinsdale Foot & Ankle Specialist in Hinsdale Now Offering Stem Cell Recruitment Therapy to Help Patients with Foot & Ankle Pain

Hinsdale Foot & Ankle Specialist, is now offering stem cell recruitment therapy to help patients with foot and ankle pain. The regenerative medicine treatments are offered by Dr. Kevin Salvino, a Board Certified Doctor of Podiatric Medicine by the American Board of Podiatric Surgery and an Associate of the American College of Foot and Ankle Surgeons. - March 10, 2016 - Hinsdale Foot & Ankle Specialist

Patricia A. Cleary Recognized as a Professional of the Year for Three Consecutive Years by Strathmore's Who's Who Worldwide Publication

Patricia A. Cleary Recognized as a Professional of the Year for Three Consecutive Years by Strathmore's Who's Who Worldwide Publication

Patricia A. Cleary of Arlington, Virginia has been recognized as a Professional of the Year for three consecutive years by Strathmore’s Who’s Who Worldwide Edition for her outstanding contributions and achievements in the field of education. About Patricia A. Cleary Ms. Cleary has 50... - March 01, 2016 - Strathmore Worldwide

Tryten Debuts NOVA 2 Modular Medical Tablet Cart at HIMSS16

Tryten Debuts NOVA 2 Modular Medical Tablet Cart at HIMSS16

Tryten will be debuting the NOVA 2 Modular Medical Tablet Cart at HIMSS16 booth 12317. - February 29, 2016 - Tryten

Dr. Edward Paul Presents Macular Degeneration Update at Harvard

Dr. Edward Paul Presents Macular Degeneration Update at Harvard

Seventy-four percent of Americans did not know that age-related macular degeneration (AMD) is the leading cause of blindness in people in the United States over the age of 60, according to a new survey. The top choice selected was, incorrectly, glaucoma. Despite the high prevalence of AMD, the... - February 28, 2016 - Paul Vision Institute

Recursion Pharmaceuticals Supports White House Precision Medicine Initiative

Recursion Pharmaceuticals Supports White House Precision Medicine Initiative

Recursion Pharmaceuticals today announced that it is part of a group of nationally recognized private and public institutions making commitments as part of President Obama's Precision Medicine Initiative to rapidly find new treatments for ultra-rare genetic diseases. - February 25, 2016 - Recursion Pharmaceuticals

SMi’s 16th Annual Pain Therapeutics Meeting to Feature Key Updates from UCL on Translational Biomarkers Following Recent Clinical Breakthrough

University College London Provide a Special Address on Translational Biomarkers for Studying Peripheral Nerves Following Study on Linking Stress Protein and Chronic Pain in Mice. - February 25, 2016 - SAE Media Group

MR Solutions Brings New 3D, 1000X Magnification Imaging Modality to Preclinical Research

MR Solutions’ new 3D in vivo confocal microscope for use in preclinical research provides a magnification range of up to 1000 times, allowing researchers to examine cellular details within a live small animal eliminating the need for a surgical biopsy - saving time and substantially reducing costs. - February 24, 2016 - MR Solutions

ALPCO's New NT-proBNP ELISA Offers Cost Savings and Flexibility

ALPCO's New NT-proBNP ELISA Offers Cost Savings and Flexibility

ALPCO recently announced the release of its new NT-proBNP (1-76) ELISA, offering researchers investigating cardiovascular disease, kidney disease, and diabetes with a flexible, user friendly and cost effective tool. The assay is highly characterized to measure changes in levels of NT-proBNP, and... - February 23, 2016 - ALPCO

Press Releases 801 - 850 of 1,659